Federal Register of Legislation - Australian Government

Primary content

PB 37 of 2013 Determinations/Health as made
This determination amends the National Health (Weighted average disclosed price - main disclosure cycle) Determination 2013 (No. 1) (No. PB 26 of 2013) to amend the weighted average disclosure price (WAPD) and the adjusted approved ex-manufacturer price for two brands of pharmaceutical items that were incorrect in the Principal Instrument because an out of date quantity was used for one brand of pharmaceutical item with the drug etoposide administered by injection when working out the WADP for all brands with that drug and manner of administration.
Administered by: Health
Registered 08 Jul 2013
Tabling HistoryDate
Tabled Senate12-Nov-2013
Tabled HR12-Nov-2013
Date of repeal 10 Jul 2013
Repealed by Division 1 of Part 5A of the Legislative Instruments Act 2003

PB 37 of 2013

National Health (Weighted average disclosed price – main disclosure cycle) Amendment Determination 2013 (No. 2)

National Health Act 1953

I, FELICITY McNEILL, First Assistant Secretary, Pharmaceutical Benefits Division, Department of Health and Ageing, delegate of the Minister for Health, make this amendment determination under subsection 99ADB(4) of the National Health Act 1953.

Dated     4   July 2013

 

 

 

 

 

 

 

 

 

FELICTY McNEILL

 

First Assistant Secretary

Pharmaceutical Benefits Division

Department of Health and Ageing

 


1              Name of Determination

       (1)     This Determination is the National Health (Weighted average disclosed price – main disclosure cycle) Amendment Determination 2013 (No. 2).

       (2)     This Determination may also be cited as PB 37 of 2013.

2              Commencement

                This Determination commences on the day after it is registered.

 

 

3              Amendments to PB 26 of 2013

Schedule 1 amends the National Health (Weighted average disclosed price – main disclosure cycle) Determination 2013 (No. 1) (PB 26 of 2013).


Schedule 1             Amendments

 

 

[1]      Schedule 1

omit:

 

317

Etoposide

Powder for I.V. infusion 1 g (as phosphate)

Injection

Etopophos

174.65

 

Insert:

 

317

Etoposide

Powder for I.V. infusion 1 g (as phosphate)

Injection

Etopophos

174.62

 

 

             omit:

 

319

Etoposide

Solution for I.V. infusion 100 mg in 5 mL vial

Injection

Etoposide Ebewe

17.47

 

insert:

 

319

Etoposide

Solution for I.V. infusion 100 mg in 5 mL vial

Injection

Etoposide Ebewe

87.33

 

Note

1.       All legislative instruments and compilations are registered on the Federal Register of Legislative Instruments kept under the Legislative Instruments Act 2003. See http://www.comlaw.gov.au/Home